Reagent anti-d bioclone 150ML monoclonal
Ended Awarded Last action
- Contract number
- SPE2D325F383T
- Awardee
-
Quidelortho Sales Company, LLC UEI ZFXRG96JMJ39
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $1,037
Award facts
- Contract value 100% obligated
- $1,037.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Raritan, NJ 08869, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency issued a delivery order to Quidelortho Sales Company, LLC on September 3, 2025, with a ceiling value of $1,037.23 for Reagent Anti-D Bioclone 150ML monoclonal, with ultimate completion on September 8, 2025. Quidelortho is a HUBZone-certified joint venture.
Place of performance is Raritan, NJ. The order is priced firm fixed price with no set-aside.
Quick answers
Who was awarded contract SPE2D325F383T?
SPE2D325F383T was awarded to Quidelortho Sales Company, LLC by Medical Supply Chain (Troop Support) on September 3, 2025.
How much is contract SPE2D325F383T worth?
The government has obligated $1,037 on SPE2D325F383T.
Is contract SPE2D325F383T an order under another contract?
Yes. SPE2D325F383T is a delivery order under SPE2D018D0005, an indefinite delivery contract.
Was contract SPE2D325F383T competed?
The extent of competition for SPE2D325F383T was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award